ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
127.552,25
-0,16%
S&P 500
5.321,89
0,26%
US Dollar vs BRL
5,1153
0,21%
Bitcoin
69.379,47
-2,90%
Brent Oil
82,695
-1,00%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Personalis Inc (PSNL)

  7. Personalis Inc (PSNL) Notícias

PSNL

Personalis (PSNL)

Personalis Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:PSNL
DataHoraFonteTítuloCódigoCompanhia
17/05/202417:05Business WirePersonalis Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:PSNLPersonalis Inc
08/05/202417:01Business WirePersonalis Reports First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
08/05/202417:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PSNLPersonalis Inc
24/04/202417:01Business WirePersonalis to Announce First Quarter 2024 Financial ResultsNASDAQ:PSNLPersonalis Inc
28/03/202417:01Business WirePersonalis to Present at the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
28/03/202410:00Business WireData Showcasing NeXT Personal MRD Test to be Presented at the 2024 American Association for Cancer Research (AACR) Annual MeetingNASDAQ:PSNLPersonalis Inc
26/03/202410:00Business WirePersonalis Announces Publication Validating NeXT Personal® Test for Ultra-sensitive MRD Detection and Cancer Treatment Response MonitoringNASDAQ:PSNLPersonalis Inc
28/02/202418:01Business WirePersonalis Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
14/02/202418:01Business WirePersonalis to Announce Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
31/01/202418:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
31/01/202418:01Business WirePersonalis to Participate at Upcoming Investor ConferencesNASDAQ:PSNLPersonalis Inc
30/01/202411:00Business WirePersonalis and ClearNote Health Announce Partnership to Advance Epigenomic TechnologyNASDAQ:PSNLPersonalis Inc
29/01/202418:00Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:PSNLPersonalis Inc
16/01/202411:05Business WirePersonalis Announces Medicare Coverage for NeXT Dx(R) Comprehensive Genomic Tumor Profiling AssayNASDAQ:PSNLPersonalis Inc
10/01/202402:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PSNLPersonalis Inc
05/01/202411:05Business WirePersonalis Reports Preliminary Fourth Quarter and Full Year 2023 Revenue and Cash BalanceNASDAQ:PSNLPersonalis Inc
21/12/202319:15Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PSNLPersonalis Inc
05/12/202318:07Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PSNLPersonalis Inc
05/12/202318:05Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:PSNLPersonalis Inc
04/12/202311:15Business WirePersonalis Extends Cash Position Into 2026, Provides Update on Key InitiativesNASDAQ:PSNLPersonalis Inc
28/11/202318:15Business WirePersonalis and Tempus Enter into a Strategic Collaboration to Advance Cancer TestingNASDAQ:PSNLPersonalis Inc
07/11/202318:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PSNLPersonalis Inc
07/11/202318:01Business WirePersonalis Reports Third Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
26/10/202309:15Business WirePersonalis Launches NeXT Personal® Dx for Early Access Clinical Use in Residual Disease and Recurrence Detection in CancerNASDAQ:PSNLPersonalis Inc
24/10/202317:01Business WirePersonalis to Announce Third Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
21/10/202305:25Business WireAnalysis from TRACERx Study Reveals More Sensitive and Earlier ctDNA Detection in Lung Cancer Patients by Personalis' MRD TechnologyNASDAQ:PSNLPersonalis Inc
19/10/202308:15Business WirePersonalis Announces Late-Breaking NeXT Personal Abstract and Proffered Paper Presentation at ESMO 2023NASDAQ:PSNLPersonalis Inc
18/10/202308:15Business WirePersonalis Appoints Former Roche Diagnostics and GRAIL Executive Deepshikha Bhandari as SVP, Regulatory, Quality and Clinical ComplianceNASDAQ:PSNLPersonalis Inc
29/08/202317:01Business WirePersonalis to Present at the 21st Annual Morgan Stanley Global Healthcare ConferenceNASDAQ:PSNLPersonalis Inc
08/08/202317:01Business WirePersonalis Reports Second Quarter 2023 Financial ResultsNASDAQ:PSNLPersonalis Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:PSNL

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PDGR3
PDG REALT ON
BOV
HAGA3
HAGA ON
BOV
PRIO3
PETRORIO ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
COGN3
COGNA ON
BOV
SGPS3
SPRINGS ON
BOV
INBR32
Inter &
BOV
BHIA3
Grupo Casas Bahia ON
BOV
GFSA3
GAFISA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
HOOT4
HOTEIS OTHON PN
BOV
HBOR3
HELBOR ON
BOV
JHSF3
JHSF PART ON
BOV
LUPA3
LUPATECH ON
BOV
IRBR3
IRB BRASIL ON
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados